Heather C Pierce1, Jonathan M Mansbach2, Erin S Fisher3, Charles G Macias4, Brian M Pate5, Pedro A Piedra6, Ashley F Sullivan7, Janice A Espinola7, Carlos A Camargo7. 1. Department of Pediatrics, Rady Children's Hospital, University of California, San Diego, California; hpierce@rchsd.org. 2. Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; 3. Department of Pediatrics, Rady Children's Hospital, University of California, San Diego, California; 4. Department of Pediatrics, Section of Emergency Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas; 5. Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri; 6. Departments of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, Texas; and. 7. Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Abstract
OBJECTIVE: To determine the extent of variability in testing and treatment of children with bronchiolitis requiring intensive care. METHODS: This prospective, multicenter observational study included 16 academic children's hospitals across the United States during the 2007 to 2010 fall and winter seasons. The study included children<2 years old hospitalized with bronchiolitis who required admission to the ICU and/or continuous positive airway pressure (CPAP) within 24 hours of admission. Among the 2207 enrolled patients with bronchiolitis, 342 children met inclusion criteria. Clinical data and nasopharyngeal aspirates were collected. RESULTS: Respiratory distress severity scores and intraclass correlation coefficients were calculated. The study patients' median age was 2.6 months, and 59% were male. Across the 16 sites, the median respiratory distress severity score was 5.1 (interquartile range: 4.5-5.4; P<.001). The median value of the percentages for all sites using CPAP was 15% (range: 3%-100%), intubation was 26% (range: 0%-100%), and high-flow nasal cannula (HFNC) was 24% (range: 0%-94%). Adjusting for site-specific random effects (as well as children's demographic characteristics and severity of bronchiolitis), the intraclass correlation coefficient for CPAP and/or intubation was 21% (95% confidence interval: 8-44); for HFNC, it was 44.7% (95% confidence interval: 24-67). CONCLUSIONS: In this multicenter study of children requiring intensive care for bronchiolitis, we identified substantial institutional variability in testing and treatment, including use of CPAP, intubation, and HFNC. These differences were not explained by between-site differences in patient characteristics, including severity of illness. Further research is needed to identify best practices for intensive care interventions for this major cause of pediatric hospitalization.
OBJECTIVE: To determine the extent of variability in testing and treatment of children with bronchiolitis requiring intensive care. METHODS: This prospective, multicenter observational study included 16 academic children's hospitals across the United States during the 2007 to 2010 fall and winter seasons. The study included children<2 years old hospitalized with bronchiolitis who required admission to the ICU and/or continuous positive airway pressure (CPAP) within 24 hours of admission. Among the 2207 enrolled patients with bronchiolitis, 342 children met inclusion criteria. Clinical data and nasopharyngeal aspirates were collected. RESULTS: Respiratory distress severity scores and intraclass correlation coefficients were calculated. The study patients' median age was 2.6 months, and 59% were male. Across the 16 sites, the median respiratory distress severity score was 5.1 (interquartile range: 4.5-5.4; P<.001). The median value of the percentages for all sites using CPAP was 15% (range: 3%-100%), intubation was 26% (range: 0%-100%), and high-flow nasal cannula (HFNC) was 24% (range: 0%-94%). Adjusting for site-specific random effects (as well as children's demographic characteristics and severity of bronchiolitis), the intraclass correlation coefficient for CPAP and/or intubation was 21% (95% confidence interval: 8-44); for HFNC, it was 44.7% (95% confidence interval: 24-67). CONCLUSIONS: In this multicenter study of children requiring intensive care for bronchiolitis, we identified substantial institutional variability in testing and treatment, including use of CPAP, intubation, and HFNC. These differences were not explained by between-site differences in patient characteristics, including severity of illness. Further research is needed to identify best practices for intensive care interventions for this major cause of pediatric hospitalization.
Authors: Mark G Thompson; Danielle R Hunt; Ali K Arbaji; Artan Simaku; Veronica L Tallo; Holly M Biggs; Carolyn Kulb; Aubree Gordon; Ilham Abu Khader; Silvia Bino; Marilla G Lucero; Eduardo Azziz-Baumgartner; Pat Shifflett; Felix Sanchez; Basima I Marar; Ilirjana Bakalli; Eric A F Simões; Min Z Levine; Jennifer K Meece; Angel Balmaseda; Tareq M Al-Sanouri; Majlinda Dhimolea; Joanne N de Jesus; Natalie J Thornburg; Susan I Gerber; Lionel Gresh Journal: BMC Infect Dis Date: 2017-03-22 Impact factor: 3.090
Authors: Jose C Flores-González; Juan Mayordomo-Colunga; Iolanda Jordan; Alicia Miras-Veiga; Cristina Montero-Valladares; Marta Olmedilla-Jodar; Andrés J Alcaraz-Romero; Miren Eizmendi-Bereciartua; Francisco Fernández-Carrión; Carmen Santiago-Gutierrez; Esther Aleo-Luján; Sonia Pérez-Quesada; Cristina Yun-Castilla; Carmen Martín; Álvaro Navarro-Mingorance; Concha Goñi-Orayen Journal: Biomed Res Int Date: 2017-03-22 Impact factor: 3.411
Authors: Anna Condella; Jonathan M Mansbach; Kohei Hasegawa; Peter S Dayan; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo Journal: West J Emerg Med Date: 2018-04-05
Authors: Jonathan M Mansbach; Kohei Hasegawa; Ruth J Geller; Janice A Espinola; Ashley F Sullivan; Carlos A Camargo Journal: Pediatr Res Date: 2019-10-04 Impact factor: 3.756